InsiderTrades

Form 4 for TXG 10x Genomics, Inc.

Accepted 2023-07-21 00:00:00 ET · period of report 2023-07-19 · accession 0001610717-23-000214 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2023-07-21 2023-07-19 TXG Hindson Benjamin J. See Remarks, Dir M - OptEx $5.49 +13.9K 297.2K +5% +$76.5K
DT 2023-07-21 2023-07-19 TXG Hindson Benjamin J. See Remarks, Dir S - Sale+OE $60.03 -13.9K 284.2K -5% -$836.8K
DMT 2023-07-21 2023-07-19 TXG Hindson Benjamin J. See Remarks, Dir M - OptEx $0.00 -13.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-07-19 M A 968 $11.48 298,176 D — —
2 Common Class A Common Stock 2023-07-19 S D 13,940 $60.03 284,236 D — — (F2) This transaction was executed in multiple trades at prices ranging from $60.00 to $60.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3 Common Class A Common Stock 2023-07-19 M A 12,972 $5.04 297,208 D — —
4 Derivative Stock Option (right to buy) 2023-07-19 M D 968 $0.00 30,282 D $11.48 · — to 2029-05-10 968 Class A Common Stock (F3) All of the shares subject to the option are fully vested and exercisable as of the date hereof.
5 Derivative Stock Option (right to buy) 2023-07-19 M D 12,972 $0.00 0 D $5.04 · — to 2028-11-02 12,972 Class A Common Stock (F3) All of the shares subject to the option are fully vested and exercisable as of the date hereof.